Phebra Naproxen Suspension (Naproxen)
naproxen 125 mg/5 mL oral liquid, 474 mL · ORAL · PBS code 5397C
RESTRICTEDWhat it costs
AU$102.47 PBS-determined price per 1 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2012-12-01.
- • Repeats: 3.
- • PBS program: PL.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Severe pain
Patient must be undergoing palliative care; AND
Patient must be unable to take a solid dose form of a non-steroidal anti-inflammatory agent.
Sponsor: Phebra Pty Ltd ABN 99 059 357 890
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.